Potency of 10 BCG vaccines as evaluated by their influence on the bacillemic phase of experimental airborne tuberculosis in guinea-pigs
- PMID: 387796
- DOI: 10.1016/s0092-1157(79)80021-9
Potency of 10 BCG vaccines as evaluated by their influence on the bacillemic phase of experimental airborne tuberculosis in guinea-pigs
Similar articles
-
Approaches to the validation of animal test systems for assay of protective potency of BCG vaccines.J Biol Stand. 1977;5(2):131-8. doi: 10.1016/0092-1157(77)90007-5. J Biol Stand. 1977. PMID: 407231
-
A single dose of killed Mycobacterium bovis BCG in a novel class of adjuvant (Novasome) protects guinea pigs from lethal tuberculosis.Vaccine. 2004 Feb 25;22(8):1063-71. doi: 10.1016/j.vaccine.2003.05.002. Vaccine. 2004. PMID: 15161084
-
The protective effect of the Mycobacterium bovis BCG vaccine is increased by coadministration with the Mycobacterium tuberculosis 72-kilodalton fusion polyprotein Mtb72F in M. tuberculosis-infected guinea pigs.Infect Immun. 2004 Nov;72(11):6622-32. doi: 10.1128/IAI.72.11.6622-6632.2004. Infect Immun. 2004. PMID: 15501795 Free PMC article.
-
Evaluation of the protective potency of new tuberculosis vaccines.Rev Infect Dis. 1989 Mar-Apr;11 Suppl 2:S484-90. doi: 10.1093/clinids/11.supplement_2.s484. Rev Infect Dis. 1989. PMID: 2652259 Review.
-
Mechanisms of cell accumulation induced by Mycobacterium bovis BCG.Mem Inst Oswaldo Cruz. 1997;92 Suppl 2:227-32. doi: 10.1590/s0074-02761997000800033. Mem Inst Oswaldo Cruz. 1997. PMID: 9698940 Review.
Cited by
-
Vaccination with Mycobacterium bovis BCG affects the distribution of Fc receptor-bearing T lymphocytes in experimental pulmonary tuberculosis.Infect Immun. 1989 May;57(5):1374-9. doi: 10.1128/iai.57.5.1374-1379.1989. Infect Immun. 1989. PMID: 2523350 Free PMC article.
-
Expression of Mycobacterium tuberculosis and Mycobacterium leprae proteins by vaccinia virus.Infect Immun. 1990 Dec;58(12):4089-98. doi: 10.1128/iai.58.12.4089-4098.1990. Infect Immun. 1990. PMID: 2123833 Free PMC article.
-
Comparison between immunopotency tests and specific active or passive acquired resistance against Mycobacterium tuberculosis in mice induced with three different preparations of BCG pasteur vaccine.Clin Exp Immunol. 1983 Oct;54(1):143-50. Clin Exp Immunol. 1983. PMID: 6413106 Free PMC article.
-
A Modified Bacillus Calmette-Guérin (BCG) Vaccine with Reduced Activity of Antioxidants and Glutamine Synthetase Exhibits Enhanced Protection of Mice despite Diminished in Vivo Persistence.Vaccines (Basel). 2013 Jan 11;1(1):34-57. doi: 10.3390/vaccines1010034. Vaccines (Basel). 2013. PMID: 26343849 Free PMC article.
-
Comparison of immune responses of mice immunized with five different Mycobacterium bovis BCG vaccine strains.Infect Immun. 1996 Jan;64(1):1-9. doi: 10.1128/iai.64.1.1-9.1996. Infect Immun. 1996. PMID: 8557324 Free PMC article.